In vitro, overexpressed Spry2 inhibited the growth and migration of HCT116 human colon cancer cells which was concomitantly accompanied by an increase in the expression of PTEN and reduction in phosphorylation of ERK and Akt. Here, SPRY2 is linked to malignant colon neoplasm.